NEW YORK, NY -- (Marketwire) -- 05/17/12 -- American Penny Stocks Research
Report Pioneer PennyStocksGuru.net is offering its VIP membership for free to
investors and traders looking to successfully navigate the Micro Cap and
Small Cap Markets.
Great Wall Builders (OTCBB: GWBU) has become a frequent pick on
PennyStocksGuru.net's watch list and has been alerted since May 3rd, 2012
when it was trading around $0.66. Check the initial coverage here:
PennyStocksGuru.net on Yahoo Finance
(http://finance.yahoo.com/news/pennystocksguru-net-issues-trend-analysis-133000648.html)
GWBU is seeing a second consecutive red day with shares dipping another 7%
today despite a opening slightly higher today. GWBU is receiving major
investor attention and should become a very hot stock in the next weeks.
PennyStocksGuru.net discovered that GWBU is currently undergoing a large
marketin... (more)
BISHOPS STORTFORD, UNITED KINGDOM -- (Marketwire) -- 05/17/12 -- Dotmatics, a
leading provider of informatics solutions and services to the pharmaceutical
and biotechnology industries, announced today that Progenra Inc. has decided
to license their suite of scientific informatics solutions to boost their
research and development process.
Progenra is a biotechnology company dedicated to finding new medicines for a
variety of diseases through the ubiquitin pathway. Progenra have replaced
their conventional software provider with the progressive and integrated
Dotmatics platform wh... (more)
MILAN, ITALY -- (Marketwire) -- 05/17/12 -- MolMed S.p.A. (MILAN:MLM) today
announced that six abstracts featuring its investigational therapeutics
NGR-hTNF and TK have been accepted for presentation at the 48th ASCO Annual
Meeting, that will take place in Chicago (IL, USA) from June 1-5, 2012. The
abstracts are now available on the ASCO 2012 website
(http://chicago2012.asco.org).
Claudio Bordignon, MolMed's Chairman and CEO, comments: "This year yet again
we had an important number of abstracts accepted at ASCO, including the
concept and design of our ongoing cell therapy Phase... (more)
NEW YORK, NY -- (Marketwire) -- 05/15/12 -- Global medical device makers
boosted research and development in an effort to combat threatened
reimbursement cuts last year, according to Kalorama Information. The
healthcare market research publisher found that the world medical device
market grew to $322 billion, with sales growth of five percent mostly the
result of product innovations and sales to emerging markets. The industry
will face challenges in the coming years with a series of austerity programs
in major world healthcare systems, according to Kalorama Information's
report... (more)
Rosangela Checchia, Chief Executive Officer, Checon Pesquisa,
New York, NY, May 16, 2012 - (ACN Newswire) - "We live in an environment of
continuous change and unlimited access to knowledge. Given the regulatory
issues, constraints and ethical aspects involved in the pharmaceutical
industry, knowing how to act in this reality is critical," says Rosangela
Checchia, Chief Executive Officer, Checon Pesquisa. There are new metrics in
the market that can help pharmaceutical marketing executives overcome some of
these challenges, increase profitability and become more accurate in
decis... (more)
Subscribe to Biotech News Journal Email News Alerts
Subscribe via RSS
Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.